Psychedelic Medicine Exceptionalism.

IF 17 1区哲学 Q1 ETHICS

American Journal of Bioethics Pub Date : 2025-01-01 Epub Date: 2025-01-13 DOI:10.1080/15265161.2025.2434398

I Glenn Cohen, Mason Marks

引用次数: 0

Abstract

Research on psychedelic medicines is experiencing a revival. Some clinicians, scientists, and ethicists believe that psychedelics are so different from other treatments that they warrant special consideration in how they are researched, regulated, commercialized, and administered. Others argue that psychedelic medicines show clinical potential, but they should be treated like other medical interventions. In other words, identical standards should apply. This article analyzes whether psychedelic medicines warrant special consideration from a regulatory and ethical perspective.

查看原文本刊更多论文

例外论。

对致幻剂的研究正在复苏。一些临床医生、科学家和伦理学家认为，致幻剂与其他治疗方法是如此不同，因此在如何研究、管理、商业化和管理致幻剂方面需要特别考虑。其他人则认为迷幻药具有临床潜力，但它们应该像其他医疗干预一样被对待。换句话说，应该采用相同的标准。本文从监管和伦理的角度分析了迷幻药是否值得特别考虑。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

American Journal of Bioethics 社会科学-科学史与科学哲学

CiteScore

12.30

自引率

26.90%

发文量

250

审稿时长

6-12 weeks

期刊介绍： The American Journal of Bioethics (AJOB) is a renowned global publication focused on bioethics. It tackles pressing ethical challenges in the realm of health sciences. With a commitment to the original vision of bioethics, AJOB explores the social consequences of advancements in biomedicine. It sparks meaningful discussions that have proved invaluable to a wide range of professionals, including judges, senators, journalists, scholars, and educators. AJOB covers various areas of interest, such as the ethical implications of clinical research, ensuring access to healthcare services, and the responsible handling of medical records and data. The journal welcomes contributions in the form of target articles presenting original research, open peer commentaries facilitating a dialogue, book reviews, and responses to open peer commentaries. By presenting insightful and authoritative content, AJOB continues to shape the field of bioethics and engage diverse stakeholders in crucial conversations about the intersection of medicine, ethics, and society.